Eden Research plc

LSE EDEN.L

Eden Research plc Current Liabilities for the year ending December 31, 2023: USD 3.77 M

Eden Research plc Current Liabilities is USD 3.77 M for the year ending December 31, 2023, a 59.67% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Eden Research plc Current Liabilities for the year ending December 31, 2022 was USD 2.36 M, a -3.72% change year over year.
Eden Research plc Current Liabilities for the year ending December 31, 2021 was USD 2.45 M, a 16.61% change year over year.
Eden Research plc Current Liabilities for the year ending December 31, 2020 was USD 2.10 M, a 15.68% change year over year.
Eden Research plc Current Liabilities for the year ending December 31, 2019 was USD 1.82 M, a 62.94% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

LSE: EDEN.L

Eden Research plc

CEO	Mr. Sean Michael Smith
IPO Date	May 11, 2012
Location	United Kingdom
Headquarters	67C Innovation Drive
Employees	19
Sector	Consumers Staples
Industries Personal Care Agriculture Cleaning Supplies Consumer Packaged Goods Cosmetics Organic Foods Pet Food Pharmaceuticals

Description

Eden Research plc offers sustainable solutions for crop protection, animal health, and consumer products in the United Kingdom and rest of Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications. It also offers animal health products, such as companion animal, bio-control, parasite treatments, and insect spray products. In addition, the company provides human health products comprising head-lice treatment products, fragrances, deodorants, wound-care products, food flavorings, odor neutralizers, and active ingredient supply/delivery products. The company was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.

Key trends

Past 5 years